Skip to main content
HCTI
NASDAQ Technology

Q1 Revenue Surges 166% on $50M Acquisition, But Net Loss Widens to $6.2M Amid Heavy Dilution

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$2.21
Mkt Cap
$4.309M
52W Low
$2.06
52W High
$7,469.928
Market data snapshot near publication time

summarizeSummary

Healthcare Triangle reported a 166% revenue increase to $9.855 million in Q1 2026, driven by a $50 million acquisition, but net loss widened to $6.198 million and cash burn intensified, necessitating significant dilutive equity raises and debt conversions.


check_boxKey Events

  • Transformational Acquisition Detailed

    The company finalized the financial details of its $50 million acquisition of Teyame and Datono, effective January 1, 2026. The consideration included $12 million in common stock, $18 million in preferred stock (to be issued), and a $5 million earnout in preferred stock, significantly expanding operations into AI-powered customer engagement services.

  • Revenue Surges 166%

    Net revenue for Q1 2026 increased by 166% to $9.855 million, up from $3.704 million in Q1 2025, primarily due to the newly acquired Customer Engagement Services segment contributing $6.875 million.

  • Net Loss Widens Significantly

    Despite revenue growth, the net loss for Q1 2026 widened to $6.198 million, compared to a net loss of $1.700 million in Q1 2025, indicating increased operational costs and non-cash expenses related to the acquisition.

  • Increased Negative Operating Cash Flow

    Net cash used in operating activities increased to $6.864 million in Q1 2026, up from $5.557 million in Q1 2025, highlighting a growing cash burn rate.


auto_awesomeAnalysis

This quarterly report provides the first consolidated financial picture following the company's massive $50 million acquisition of Teyame and Datono, a transformational event for a company with a $4.3 million market cap. While the acquisition drove a substantial 166% increase in revenue, it also led to a significant widening of net loss and increased negative operating cash flow. The company relied heavily on dilutive equity financing and debt conversion to fund operations and the acquisition, which is a critical concern for a micro-cap entity. The drop in the current ratio below 1.0 indicates ongoing liquidity challenges despite management's assertion of sufficient resources.

At the time of this filing, HCTI was trading at $2.21 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $2.06 to $7,469.93. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HCTI - Latest Insights

HCTI
May 13, 2026, 8:19 PM EDT
Filing Type: 10-Q
Importance Score:
9
HCTI
Apr 15, 2026, 4:25 PM EDT
Source: Wiseek News
Importance Score:
9
HCTI
Apr 15, 2026, 4:23 PM EDT
Filing Type: 10-K
Importance Score:
9
HCTI
Apr 10, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
HCTI
Apr 08, 2026, 4:10 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
HCTI
Apr 07, 2026, 5:05 PM EDT
Filing Type: 8-K/A
Importance Score:
9
HCTI
Mar 31, 2026, 4:01 PM EDT
Filing Type: 424B5
Importance Score:
9
HCTI
Mar 11, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
HCTI
Feb 27, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
9
HCTI
Feb 27, 2026, 12:12 PM EST
Filing Type: 424B5
Importance Score:
9